Moberg Pharma AB (publ)
STO:MOB

Watchlist Manager
Moberg Pharma AB (publ) Logo
Moberg Pharma AB (publ)
STO:MOB
Watchlist
Price: 11.97 SEK -5.52%
Market Cap: 558.9m SEK
Have any thoughts about
Moberg Pharma AB (publ)?
Write Note

Moberg Pharma AB (publ)
Long-Term Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Moberg Pharma AB (publ)
Long-Term Debt Peer Comparison

Comparables:
CALTX
CAMX
S
SECARE
IRLAB A
I
FLERIE

Competitive Long-Term Debt Analysis
Latest Figures & CAGR of Competitors

Company Long-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
Moberg Pharma AB (publ)
STO:MOB
Long-Term Debt
kr3.5m
CAGR 3-Years
-10%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Calliditas Therapeutics AB
STO:CALTX
Long-Term Debt
kr1B
CAGR 3-Years
562%
CAGR 5-Years
191%
CAGR 10-Years
N/A
Camurus AB
STO:CAMX
Long-Term Debt
kr10.6m
CAGR 3-Years
-16%
CAGR 5-Years
-15%
CAGR 10-Years
N/A
S
Swedencare AB (publ)
STO:SECARE
Long-Term Debt
kr1.6B
CAGR 3-Years
83%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
IRLAB Therapeutics AB
STO:IRLAB A
Long-Term Debt
kr24.6m
CAGR 3-Years
169%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
I
InDex Pharmaceuticals Holding AB
STO:FLERIE
Long-Term Debt
kr700k
CAGR 3-Years
-19%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Moberg Pharma AB (publ)'s Long-Term Debt?
Long-Term Debt
3.5m SEK

Based on the financial report for Dec 31, 2023, Moberg Pharma AB (publ)'s Long-Term Debt amounts to 3.5m SEK.

What is Moberg Pharma AB (publ)'s Long-Term Debt growth rate?
Long-Term Debt CAGR 3Y
-10%

Over the last year, the Long-Term Debt growth was -13%. The average annual Long-Term Debt growth rates for Moberg Pharma AB (publ) have been -10% over the past three years .

Back to Top